학술논문

Metabolic, Intestinal, and Cardiovascular Effects of Sotagliflozin Compared With Empagliflozin in Patients With Type 2 Diabetes: A Randomized, Double-Blind Study
Document Type
Article
Source
In: Diabetes Care. (Diabetes Care, September 2022, 45(9):2118-2126)
Subject
Language
English
ISSN
19355548
01495992